Frédérique Penault–Llorca
Centre Jean Perrin(FR)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies
Most-Cited Works
- → Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis(2010)2,133 cited
- → Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group(2011)1,975 cited
- → KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab(2008)1,450 cited
- → Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial(2009)298 cited
- → Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer(2020)198 cited
- → HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients(2007)185 cited
- → Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group(2020)161 cited
- → Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer(2003)113 cited
- → French multicentric validation ofALKrearrangement diagnostic in 547 lung adenocarcinomas(2015)58 cited
- → High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: A multicentre GEFPICS study(2006)51 cited